11 February 2021 : Clinical Research
Effect of ¹³¹I Therapy on Complete Blood Count in Patients with Differentiated Thyroid Cancer
Zhongying Rui1CDEF, Ruixin Wu1BCD, Wei Zheng1ADG*, Xuan Wang1BDF, Zhaowei Meng1AF, Jian Tan1AFDOI: 10.12659/MSM.929590
Med Sci Monit 2021; 27:e929590
Figure 3 Changes in monocyte counts after cumulative doses of 131I therapy. The number of monocytes decreased when patients had received ≤5550 MBq of 131I and then gradually increased after patients had received >5550 MBq of 131I. While there were no statistically significant differences between post-treatment and baseline values, patients who received >11 100 MBq of 131I had higher monocyte counts than those who received ≤5550 MBq of 131I (0.30±0.09 vs 0.22±0.05, P=0.003).